Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer An Open Label Prospective Phase I b Study

NCT01248611 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT01248611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01248611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer An Open Label Prospective Phase I b Study
Lead sponsor
St. Olavs Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2011
Completion date
September 30, 2011
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chronic pain